Heavy smoking in adult males significantly increases oxidative stress, inflammation, and vascular dysfunction, as shown by ...

A research team has developed a new class of compounds that effectively inhibit both wild-type CDK9 and its drug-resistant ...

In a recent study posted to the journal Hematology, Transfusion, and Cell Therapy, researchers determined whether some hematological parameters can be used as biomarkers to facilitate severe acute ...

In recent years, the therapeutic landscape for hematological malignancies has undergone a profound transformation, driven by the development and regulatory ...

Extrahepatic portal vein obstruction can be caused by hematological diseases (e.g. hyper-coagulable states, myeloproliferative disorders), intra-abdominal infections (e.g. omphalitis in children ...

Effect of BMI on CAR T-cell therapy outcomes: Real-world analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.

The management of hematological malignancies (HM) in renally impaired patients may be a difficult task. Indeed, the kidney represents a major elimination pathway for many chemotherapeutic agents ...

NCI-CTCAE grading of hematological toxicity among patients with prolonged toxicity (i.e., ≥ 12 months).